Wall Street's analyst corps delivered a flurry of rating changes today, and if you're keeping score at home, the standout move belongs to Uber Technologies, Inc. (UBER). Arete Research analyst Oliver Lester didn't just upgrade the ride-hailing giant from Neutral to Buy—he boosted the price target from $82 to $125. That's a 43% rally from Tuesday's closing price of $87.57, which is the kind of call that makes people pay attention.
But Uber wasn't the only stock getting attention. Here's the full rundown of ten analyst moves that landed on desks this morning.
Cybersecurity and Tech Get the Love
BMO Capital analyst Keith Bachman raised his price target on CrowdStrike Holdings, Inc. (CRWD) from $500 to $555, maintaining an Outperform rating. The cybersecurity company's shares closed at $516.55 on Tuesday, so this suggests there's still room to run despite an already impressive year.
Over in semiconductor equipment land, B of A Securities analyst Didier Scemama lifted the price target for ASML Holding N.V. (ASML) from $1,092 to $1,331 while keeping a Buy rating. ASML shares closed at $1,108.78 on Tuesday, and the new target implies the Dutch chipmaking equipment supplier has another 20% in the tank.
Marvell Technology, Inc. (MRVL) also caught a bid from Rosenblatt analyst Kevin Cassidy, who increased his price target from $95 to $120 while maintaining a Buy rating. Marvell shares settled at $92.89 on Tuesday, putting that target about 29% above current levels.
Healthcare Takes Some Hits
Not everyone had a good day. Leerink Partners analyst Joseph Schwartz downgraded BioMarin Pharmaceutical Inc. (BMRN) from Outperform to Market Perform and slashed the price target from $82 to $60. BioMarin shares closed at $53.89 on Tuesday, which means they're already trading below even the reduced target.
Leerink wasn't done handing out bad news. The firm also cut Acadia Healthcare Company, Inc. (ACHC) from Outperform to Market Perform, dropping the price target from $25 to $14. Analyst Whit Mayo clearly sees challenges ahead for the behavioral healthcare provider, whose shares closed at $16.49 on Tuesday.
Industrial Names See Mixed Action
On the positive side, Baird analyst Richard Eastman raised his price target on Donaldson Company, Inc. (DCI) from $85 to $96, maintaining an Outperform rating. The filtration systems manufacturer closed at $88.16 on Tuesday, suggesting about 9% upside if Baird's view plays out.
JP Morgan analyst Tomohiko Sano got even more enthusiastic about CSW Industrials, Inc. (CSW), upgrading the stock from Neutral to Overweight and raising the price target from $300 to $350. CSW Industrials shares closed at $277.21 on Tuesday, so that new target implies roughly 26% upside.
Retail and Software Round Out the List
Telsey Advisory Group analyst Dana Telsey raised her price target on Signet Jewelers Limited (SIG) from $92 to $96 while maintaining a Market Perform rating. Signet shares settled at $89.19 on Tuesday, putting them within striking distance of that target.
Finally, Needham analyst Mike Cikos trimmed his price target on GitLab Inc. (GTLB) from $55 to $50 but maintained a Buy rating. GitLab shares closed at $43.37 on Tuesday, which means even with the reduced target, Cikos sees about 15% upside for the DevOps platform company.
What It All Means
The big theme here? Tech and industrials are drawing bullish calls, while healthcare is facing some skepticism. The Uber upgrade stands out not just for the size of the implied move, but because it represents a shift from neutral to bullish—those are the kinds of rating changes that can move stocks in the near term.
As always, analyst price targets are educated guesses about where stocks might trade over the next 12 to 18 months. They're worth considering as part of your research, but they shouldn't be the only factor in your investment decisions. Markets have a funny way of ignoring even the smartest forecasts when conditions change.
